ArticleFrontiers in pharmacology2022

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma.

Lulu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.